COVID-19 Now and Beyond: Where Do We Go From Here?
Although the COVID-19 Public Health Emergency (PHE) Declaration expired on May 11, 2023, COVID-19 continues to be top of mind in the healthcare community. Pharmacists have been integral in the fight against COVID-19. This educational activity will provide an update on the pharmacist’s role in current COVID-19 prevention and treatment strategies. Now that the PHE Declaration has expired, the potential implications of coverage and access to vaccines, therapies, and tests will be explained. Prevention and management strategies for COVID-19 in special patient populations will also be summarized. The activity will conclude with a review of new and emerging therapies for the prevention and treatment of COVID-19.
Tuesday, Dec. 5
11:30 a.m. - 1 p.m. PT (2:30 - 4 p.m. ET)
Symposium Location: Room 157,100 Level, Anaheim Convention Center – North
Come early! Seating is limited and provided on a first-come, first-served basis.
Can't make it to Anaheim? Tune into the Free Live Webinar Broadcast.
Registration is required for the webinar.
PharmD, MPH, FCSHP, Activity Chair
Health Sciences Clinical Professor
University of California, San Francisco (UCSF) School of Pharmacy
Infectious Diseases, Clinical Pharmacist
UCSF Medical Center
San Francisco, California
Katherine Yang, PharmD, MPH, FCSHP is a Health Sciences Clinical Professor of Pharmacy at the UCSF School of Pharmacy and an infectious diseases clinical pharmacist at the UCSF Medical Center in San Francisco, California. Dr. Yang specializes in the pharmacokinetic and pharmacodynamic optimization of antibiotic dosing for the treatment of multi-drug resistant gram-negative infections. Since the start of the pandemic, Dr. Yang has been heavily involved in the management of COVID-19 therapeutics.
Monica V. Mahoney,
PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP
Clinical Pharmacy Specialist
Beth Israel Deaconess Medical Center
Monica Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP is a clinical pharmacy specialist in the outpatient infectious diseases and outpatient parenteral antibiotic therapy clinics at Beth Israel Deaconess Medical Center. Dr. Mahoney received her PharmD degree from Massachusetts College of Pharmacy and Health Sciences in Boston, Massachusetts. She completed postgraduate year 1 residency and postgraduate year 2 infectious diseases residency at Tufts Medical Center in Boston, Massachusetts. She is an active member of many pharmacy and infectious diseases professional organizations, including ASHP, the Society of Infectious Diseases Pharmacists, the Infectious Diseases Society of America, and the Society for Healthcare Epidemiology of America.
Clinical Pharmacy Specialist Pediatric Infectious Diseases
Antimicrobial Stewardship, Cystic Fibrosis
The Children's Hospital of the King's Daughters
Sarah Parsons, PharmD, BCPPS is a clinical pharmacy specialist in pediatric infectious diseases at the Children’s Hospital of the King’s Daughters focusing in antimicrobial stewardship and COVID-19 management in pediatric patients. Dr. Parsons received her Bachelor of Science focused in microbiology and immunology from Radford University followed by her Doctor of Pharmacy Degree from Virginia Commonwealth School of Pharmacy. She completed a postgraduate year 1 residency at HCA Health system in Richmond, Virginia.
PharmD, MS, BCPS, FASHP
Senior Director, Pharmacy Practice and Quality
Michael Ganio, PharmD, MS, BCPS, FASHP joined the staff at ASHP as Director of Pharmacy Practice and Quality in January of 2018. As a member of the Center on Medication Safety and Quality team, his responsibilities span the practice of pharmacy and include drug shortages, pharmaceutical quality, sterile and non-sterile drug compounding practices, hazardous drug handling, and the ASHP Standardize 4 Safety initiative. Dr. Ganio earned his PharmD from the Rutgers University Ernest Mario School of Pharmacy and his Master’s degree in Health-System Pharmacy Administration from The Ohio State University College of Pharmacy. He completed a PGY1 Pharmacy Practice residency at The Ohio State University Wexner Medical Center. Dr. Ganio is a Board Certified Pharmacotherapy Specialist (BCPS) and is a Certified Professional in Healthcare Information and Management Systems (CPHIMS).
This activity was planned to meet the educational needs of pharmacists who practice in hospitals and health systems.
- Describe the pharmacist’s role in COVID-19 prevention and treatment strategies.
- Discuss barriers to equitable access to COVID-19 vaccines and therapeutics.
- Assess prevention and management strategies for COVID-19 in special patient populations.
- Evaluate new and emerging therapies for the prevention and treatment of COVID-19.
- 11:30 a.m. – Welcome and Introductions
- 11:35 a.m. – The Current State of COVID-19
- 11:50 a.m. – Special Populations: What We Know, What We Don’t Know
Monica V. Mahoney and Sarah Parsons
- 12:20 p.m. – Emerging Therapies for the Prevention and Treatment of COVID-19
Katherine Yang, Monica V. Mahoney, and Sarah Parsons
- 12:50 p.m. – Faculty Discussion, Questions and Answers
Accredited for CPE
ACPE #: 0204-0000-23-412-L01-P
CE Credit: 1.5 contact hours (0.15 CEUs)
Activity Type: Application-based
Activity Fee: No charge
To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.
|The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.|
|Provided by ASHP.
Supported by an educational grant from AstraZeneca.
For questions and assistance to participate, contact us.